Welcome to CDC Stacks | Duration of protection against hepatitis A for the current two-dose vaccine compared to a three-dose vaccine schedule in children - 36501 | CDC Public Access | Arctic Investigations Program
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Duration of protection against hepatitis A for the current two-dose vaccine compared to a three-dose vaccine schedule in children
Filetype[PDF - 108.10 KB]


Details:
No Related Documents.
You May Also Like:
  1. Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies; recommendations of the Advisory Committee on Immunization Practices
    Personal Author:
    Briggs, Deborah; Brown, Catherine M.; Cieslak, Paul R.; Franka, Richard; Katz, Samuel L., 1927-; Kerr, Harry D.; Lett, Susan M.; Levis, Robin; Meltzer, Martin I.; Rupprecht, Charles Edward; Schaffner, William, 1937-;
    Corporate Author:
    United States, Advisory Committee on Immunization Practices.; Centers for Disease Control and Prevention (U.S.); National Center for Emerging and Zoonotic Infectious Diseases (proposed);
    Published:
    March 19, 2010
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 59, no. RR-2
    Description:
    "These recommendations of the Advisory Committee on Immunization Practices (ACIP) update the previous recommendations on human rabies prevention (CDC. Human rabies prevention---United States, 1999: recommendations of the Advisory Committee on Immuniz...
    File Type:
    Filetype[PDF - 8.72 MB]
  2. Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies : recommendations of the advisory committee on immunization practices
    Corporate Author:
    National Center for Emerging and Zoonotic Infectious Diseases (proposed); United States. Advisory Committee on Immunization Practices.;
    Published:
    March 19, 2010
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 2010; 59(RR-2):1-9.
    Description:
    This report summarizes new recommendation and updates previous recommendations of the Advisory Committee on Immunization Practices (ACIP) for postexposure prophylaxis (PEP) to prevent human rabies (CDC. Human rabies prevention---United States, 2008: ...
    Status:
    current
    File Type:
    Filetype[PDF - 8.74 MB]
  3. Risk of Injection-Site Abscess among Infants Receiving a Preservative-Free, Two-Dose Vial Formulation of Pneumococcal Conjugate Vaccine in Kenya
    Personal Author:
    Burton, Deron C.; Bigogo, Godfrey M.; Audi, Allan O.; Williamson, John; Munge, Kenneth; Wafula, Jackline; Ouma, Dominic; Khagayi, Sammy; Mugoya, Isaac; Mburu, James; Muema, Shadrack; Bauni, Evasius; Bwanaali, Tahreni; Feikin, Daniel R.; Ochieng, Peter M.; Mogeni, Ondari D.; Otieno, George A.; Olack, Beatrice; Kamau, Tatu; Van Dyke, Melissa K.; Chen, Robert; Farrington, Paddy; Montgomery, Joel M.; Breiman, Robert F.; Scott, J. Anthony G.; Laserson, Kayla F.;
    Published:
    Oct 28 2015
    Source:
    PLoS One. 10(10).
    Description:
    There is a theoretical risk of adverse events following immunization with a preservative-free, 2-dose vial formulation of 10-valent-pneumococcal conjugate vaccine (PCV10). We set out to measure this risk. Four population-based surveillance sites in K...
    File Type:
    Filetype[PDF - 535.69 KB]
  4. Mumps Antibody Response in Young Adults After a Third Dose of Measles-Mumps-Rubella Vaccine
    Personal Author:
    Fiebelkorn, Amy Parker; Coleman, Laura A.; Belongia, Edward A.; Freeman, Sandra K.; York, Daphne; Bi, Daoling; Zhang, Cheryl; Ngo, Laurie; Rubin, Steven;
    Published:
    Oct 18 2014
    Source:
    Open Forum Infect Dis. 2014; 1(3).
    Description:
    Background :  Mumps outbreaks in populations with high 2-dose measles-mumps-rubella (MMR) vaccine coverage raise the question whether a third dose of MMR vaccine (MMR3) is needed. However, data on the immunogenicity of MMR3 are limited. We assessed...
    File Type:
    Filetype[PDF - 641.77 KB]
  5. Two-dose Varicella Vaccine Effectiveness and Rash Severity in Outbreaks of Varicella Among Public School Students
    Personal Author:
    Thomas, Carrie A.; Shwe, Thein; Bixler, Dee; del Rosario, Maria; Grytdal, Scott; Wang, Chengbin; Haddy, Loretta E.; Bialek, Stephanie R.;
    Published:
    Nov 2014
    Source:
    Pediatr Infect Dis J. 33(11):1164-1168.
    Description:
    Background : Universal 2-dose varicella vaccination was recommended in 2006 to further reduce varicella disease burden. This study examined 2-dose varicella vaccine effectiveness (VE) and rash severity in the setting of school-associated varicella ou...
    File Type:
    Filetype[PDF - 181.22 KB]